Dr Bertrand Mennecier

Spécialité

Oncologue médical, expert poumon

Hôpital

Centre Hospitalier Régional Universitaire de Nancy (Nancy)

Derniers articles

• Living With ALK Fusion-Positive NSCLC: A French Nationwide Survey of the Psychosocial Impact Among Patients, Caregivers, and Health Care Professionals. (30 juin 2026)
• The effectiveness of telemonitoring, either self-administered or professionally assisted, in cancer care management: a descriptive, retrospective, observational cohort study. (15 janv. 2026)
• Alectinib Efficacy Post-Brigatinib Against Advanced ALK+ Non-Small Cell Lung Cancer (BrigALK2-GFPC 02-2019 Study). (12 août 2025)
• Central nervous system complications of immune checkpoint inhibitors: A comprehensive review. (1 févr. 2025)
• Patient-reported outcomes in CodeBreaK 200: Sotorasib versus docetaxel for previously treated advanced NSCLC with KRAS G12C mutation. (1 oct. 2024)